Quantum Genesis AI Corp. (QGAI)

OTCMKTS · Delayed Price · Currency is USD
0.340
-0.060 (-15.00%)
Mar 9, 2026, 2:58 PM EST
-66.00%
Market Cap 16.39M
Revenue (ttm) n/a
Net Income (ttm) -183.61K
Shares Out 40.97M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,000
Average Volume 57,402
Open 0.350
Previous Close 0.400
Day's Range 0.340 - 0.350
52-Week Range 0.003 - 5.040
Beta 28.24
RSI 32.48
Earnings Date Mar 17, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w... [Read more]

Sector Materials
Founded 2015
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol QGAI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.